Medicine
Kevzara 200 mg/1.14 mL injection
Kevzara 200 mg/1.14 mL injection is a prescription medicine containing Sarilumab for subcutaneous use, marketed by Sanofi-Aventis, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
and Stability Refrigerate at 36°F to 46°F (2°C to 8°C) in original carton to…
Key facts
- Active ingredient (INN)
- Sarilumab
- Brand
- Kevzara
- Strength
- 200 mg/1.14 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 2 syringes of 1.14 mL and 1 more
- Marketing authorisation holder
- Sanofi-Aventis
- Manufacturer
- Sanofi-Aventis
- Origin register
- US FDA, United States
- Storage
- and Stability Refrigerate at 36°F to 46°F (2°C to 8°C) in original carton to protect from light. Do not freeze. After removal from the refrigerator, use KEVZARA within 14 days or discard. Do not store above 77°F (25°C). If needed, patients/caregivers may store KEVZARA at room temperature up to 77°F (25°C) up to 14 days in the outer carton. Do not shake.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L04AC14 Sarilumab
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 May 2017
- Identifiers
- RxCUI 1923333, 1923338, 1923345 +5DailyMed set ID 827bc01c-d379-4266-a18c-c7f904b76af3NDC 0024-5922, 0024-5910Application BLA761037
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 syringe in 1 package / 1.14 mL in 1 syringe | 0024-5910-01 | Sanofi-Aventis | 22 May 2017 |
| 2 syringe in 1 package / 1.14 mL in 1 syringe | 0024-5910-02 | Sanofi-Aventis | 22 May 2017 |
| 2 syringe in 1 package / 1.14 mL in 1 syringe | 0024-5922-01 | Sanofi-Aventis | 13 April 2018 |
| 2 syringe in 1 package / 1.14 mL in 1 syringe | 0024-5922-02 | Sanofi-Aventis | 13 April 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Sarilumab
Clinical summary
Sarilumab is an interleukin-6 receptor antagonist indicated for treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs (DMARDs). MedsAcross supplies Sarilumab for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SarilumabFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- KEVZARA prescribing information (Sanofi-Aventis) · U.S. National Library of Medicine, DailyMed
- Kevzara: European public assessment report (EPAR) · European Medicines Agency
Need Kevzara 200 mg/1.14 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.